You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

23 July 2020

Injectable PrEP – an exciting tool, but no silver bullet for adherence

We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.

21 May 2020

Global trial of long-acting injectable PrEP for gay men and trans women stopped early following success

Long-acting, injectable cabotegravir is as effective as daily PrEP pills at preventing HIV among cisgender men and transgender women who have sex with men.

09 August 2019

Global 2020 HIV targets are off-track

An Avert spotlight on the HIV response – we reflect on the most important take-homes from the UNAIDS 2019 Global Report.

15 March 2019

5 times HIV was ‘cured’

With news of another patient ‘cured’ we look back at 5 big moments in cure research and what they really mean

13 December 2018

Harm reduction progress: Slow. Uneven. Stagnated

Harm reduction for the 15.6 million people who inject drugs remains a critical cornerstone to respond to the global epidemics of HIV and hepatitis C – but progress has stagnated.

30 November 2018

World AIDS Day at 30: the 'AIDS' identity

On the 30th anniversary of World AIDS Day, we look back at the difference in the AIDS identity from the 1980s to 2018.

26 October 2018

7 steps to hepatitis elimination

Sustained action is needed now if we are to capitalise on the opportunity to eliminate viral hepatitis by 2030.

21 September 2018

Fighting tuberculosis – the disease that doesn’t go away

Getting on top of the tuberculosis epidemic requires renewed attention, and bringing HIV out of isolation. 
 

19 September 2018

A hepatitis C cure is here, but still too few people can get it

Opportunities to increase access to the hepatitis C cure exist – but strong political will is needed and many countries are failing to benefit from cheaper generics.

12 August 2018

We know how! Responding to HIV and the youth bulge with youth voices

On International Youth Day (12 August), we look at the importance of youth involvement and safe spaces to respond to the HIV challenge related to the youth bulge.